How AI Is Transforming Pharma Commercialization | Trinity Life Sciences CEO

Jul 14, 2026

How will artificial intelligence reshape the pharmaceutical industry? In this interview, Scott Evangelista, CEO of Trinity Life Sciences, explains how the company helps pharmaceutical, biotechnology, and medical technology organizations accelerate the commercialization of innovative therapies by improving market access, product strategy, patient identification, and data-driven decision-making. He also discusses the growing challenges companies face as they prepare for AI adoption across healthcare.

Evangelista highlights Trinity’s new AI Readiness Benchmark, InsightsEdge, and Digital Twins initiatives, explaining how AI can dramatically improve market research, physician engagement, commercialization strategy, and patient access while reducing costs and accelerating innovation. Looking ahead, he shares his vision for a future where AI enables highly personalized healthcare and helps bring life-changing therapies to patients faster and more efficiently.

#TrinityLifeSciences
#ArtificialIntelligence
#AI
#Pharmaceuticals
#Biotechnology
#LifeSciences
#Healthcare
#Commercialization
#DigitalTwins
#MarketAccess
#DrugDevelopment
#HealthTech
#JaneKing
#NewsOut
#HealthcareInnovation